The popularity of Sildenafil initially fueled a period of growth for pharma, nevertheless recent shifts present a murky picture for investors. Lower-cost alternatives are reducing profits, and persistent litigation add https://gretavfso755826.humor-blog.com/39676114/sildenafil-and-pharma-a-risky-investment